GlassScriptPhysician profile
Ellen Matheson
NPI 1083446686
$1,266.68
in general payments reported to CMS, 2019-2025
13 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $205 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179 · Education: $87.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.19 |
| Education | $87.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $391.27 | 2024-2025 | |
| Pfizer INC. | $215.58 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $119.51 | 2025 | Austedo Xr |
| Biogen, INC. | $113.82 | 2025 | Vumerity, Tysabri, Skyclarys |
| Sk Life Science, INC. | $96.86 | 2025 | |
| Noctrix Health, INC. | $85.13 | 2024 | Nidra |
| Lundbeck LLC | $63.22 | 2024-2025 | Rexulti |
| Cycle Pharmaceuticals INC | $41.66 | 2025 | Tascenso Odt, Bafiertam |
| Genentech USA, INC. | $40.14 | 2025 | Ocrevus Zunovo |
| Neurelis, INC. | $34.68 | 2025 | Valtoco |
| Azurity Pharmaceuticals, INC. | $26.25 | 2025 | Horizant |
| Insightec,INC | $20.52 | 2025 | Exablate |
| Aucta Pharmaceuticals, INC. | $18.04 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Matheson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.